Grants & Projects per year
Fingerprint
Dive into the research topics where John Fetse is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bioprinted Human Triple Negative Breast Cancer Models to Investigate Novel Peptide-Based Immune Checkpoint Inhibitors
Reynolds, D. (PI) & Fetse, J. (CoPI)
Breast Cancer Coalition of Rochester
07/1/26 → 07/31/27
Project: Research
-
Development of Smart Drug Delivery Systems for Prostate Cancer Immunotherap
Fetse, J. (PI)
American Association of Colleges of Pharmacy
04/8/25 → 09/30/25
Project: Research
-
Lipid Nanoparticle Development in Practice: Challenges and Collective Insights
Lu, X., Ranjbar, S., Zhang, F., Choonara, Y., Pearson, R. M., Fetse, J., He, R., Mohamed, E., Ranjan, A., Hussain, M. D., Mohamed Kheir, A. H. O., Yen, C. W., Salem, A. K. & Mosharraf, M., Feb 2026, In: Pharmaceutical Research. 43, 2, p. 311-319 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Development of a peptide-based tumor-activated checkpoint inhibitor for cancer immunotherapy
Zhao, Z., Fetse, J., Mamani, U. F., Guo, Y., Li, Y., Patel, P., Liu, Y., Lin, C. Y., Li, Y., Mustafa, B. & Cheng, K., Jan 24 2025, In: Acta Biomaterialia. 193, p. 484-497 14 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Evidence for the anxiolytic- and antidepressant-like effects of three semi-synthetic derivatives of xylopic acid in mice
Benneh, C. K., Abotsi, W. K. M., Mante, P. K., Biney, R. P., Fetse, J. P., Abeka, M. K., Adongo, D. W. & Woode, E., Jul 2025, In: Naunyn-Schmiedeberg's Archives of Pharmacology. 398, 7, p. 8825-8844 20 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Structure-Guided Virtual Screening of Small Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy
Roundtree, I., Valdivia, R., Altenor, A., Ignac, T. S., Esposito, A., Wu-Peruzzi, K., Fuentes, G., Ginjauma, B., Acquah, F. & Fetse, J., Dec 11 2025, In: ACS Medicinal Chemistry Letters. 16, 12, p. 2415-2425 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy
Mamani, U. F., Ibrahim, M. N., Liu, Y., Fetse, J., Lin, C. Y., Kandel, S., Nakhjiri, M., Koirala, S., Guo, Y., Alahmari, M. & Cheng, K., Dec 2024, In: Pharmaceutical Research. 41, 12, p. 2275-2288 14 p., 752065.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations